The ARM Southern Great Plains Central Facility Best Estimate Radiative Flux CD

The BEFlux VAP directly compares data from the three Normal Incidence Perheliometers, shaded pyranometers, and shaded pyrgeometers at the SGP CF. Extensive analysis with several years of data has produced limits of typical ranges of agreement when these instruments are performing as expected. These limits are used to screen the data, and then the average is taken of the two that agree best, given that at least two instruments agree to within the established limits. This is done for the downwelling direct normal and diffuse shortwave, and the downwelling longwave. The total (global) downwelling shortwave is then the sum of the direct and diffuse components

Total Sky Imager Model 880 Status and Testing Results

The Total Sky Imager (TSI) is manufactured by Yankee Environmental Systems (YES) Incorporated, based in Turner Falls, Massachusetts. (For more information about YES, see http://www.yesinc.com/.) The TSI is a commercialized version of the Hemispheric Sky Imager prototype (Long et al. 1998). YES has now produced a more sophisticated (compared to the original model 440) model 880 of the TSI (see Figure 1). The first YES TSI 880 was deployed at the Blackwell Tonkawa Airport (BTA) as part of the Department of Energy (DOE) Atmospheric Radiation Measurement (ARM) Program 2000 Cloud intensive operational period (IOP). This TSI 880 collected data from March 2, 2000 through April 6, 2000. This report gives an assessment of the TSI based on the BTA and Southern Great Plane (SGP) Central Facility (CF) data collected to date

Investigation of the Downwelling LW Differences Between the Niamey AMF Main and Supplementary Sites

The overall average downwelling longwave (LW) measured at the Niamey supplementary facility (S1) is 6-8 Wm-2 less than that measured by the two instruments located at the ARM Mobile Facility (AMF) main (N1) site. Examination of all other data available at both sites does not reveal any overarching differences that suggest this should be the case. However, examination of the pyrgeometer case and dome temperatures do suggest that the S1 values are also anomalously low, which in turn would explain the downwelling LW anomaly since the LW is calculated using these temperatures. Our recommendation then is to normalize the S1 data to the average N1 value by applying an adjustment factor to the S1 downwelling pyrgeometer case and dome temperatures (in Kelvin), then recalculating the downwelling LW values. The adjustment factor (0.00305) has been determined as that factor that brings the overall average S1 LWdn to agree with the overall average of the two N1 LWdn data series. We note that there is no reason to expect that the two site averages would actually be exactly equal to one another, and thus our recommendation is viewed as likely moving the S1 data in the right direction and by normalizing to the N1 average will help facilitate more meaningful temporal variability studies at least. It is also strongly recommended that for all future AMF deployments where supplementary sites will also be deployed, that the supplementary instrument systems (complete) be assembled as they will be operated in the field and run for at least a few days beside the corresponding AMF main site instruments, both at the beginning and end of the AMF field campaign. This is absolutely crucial so that all the measurements can be compared pre- and post-experiment to properly relate these measurements and systems, and to detect measurement anomalies such as those discussed in this report

Utility of contrast-enhanced computed tomography in the evaluation of canine insulinoma location

OBJECTIVES: To determine 1) the sensitivity of contrast-enhanced CT (CECT) for detection of primary canine insulinomas and metastases 2) the sensitivity of CECT to locate canine insulinomas within the pancreas and 3) the CECT attenuation pattern of canine insulinomas and post-contrast phase in which insulinomas have the best visibility. METHODS: A retrospective review was performed of the medical records of 27 canine insulinoma patients. Simultaneous occurrence of blood glucose 10 mIU/L (reference interval: 1.4-24.5 mIU/L) were considered diagnostic for insulinoma. The dogs had a mean age of 9.0 ± 1.7 (SD) years and comprised 11 males and 17 females. RESULTS: Using CECT-scans, 26/27 insulinomas were successfully detected. However, CECT-scans predicted the correct location of insulinomas within the pancreas in only 14/27 dogs. In 9/13 inaccurately located insulinoma cases, the location error was major. There was no significant difference between triple, double and single-phase CECT-scans with location accuracies of 54%, 50% and 50%, respectively. Also, there was no specific post-contrast phase in which insulinomas could be visualised best. Detection of lymph node metastases with CECT-scans had a sensitivity of 67% (10/15 lymph node metastases). Detection of liver metastases had a sensitivity of 75% (6/8 liver metastases). This study highlights that major location errors mainly occurred if single- or double-phase CECT-scans were used (6/9 cases). CONCLUSION: It is suggested that triple-phase CECT-scans have superior outcome over single- or double-phase CECT-scans in pre-operative imaging of canine insulinomas

Near-sea-level langley calibration algorithm

As compared to other methods, measurement of aerosol optical depth (AOD) using sunphotometers offer several advantages. However, it suffers a drawback as calibration of the instrument required to be performed at high altitude due to temporal drifts in the atmospheric condition during the calibration. To solve this, a new Langley calibration algorithm has been designed for AOD measurement using spectroradiometer instrument. The key advantages of the proposed algorithm are its objectivity, computational efficiency and the ability to detect short intervals of cloud transits. It avoids travelling to high altitude mountain that the conventional calibration procedure always practiced for frequent calibration. Most importantly, neither it requires priori knowledge of the instrument calibration nor a collocated calibrated instrument for nominal calibration transfer to perform the cloud-screening procedure

Oligodendrocytes Do Not Export NAA-Derived Aspartate In Vitro.

Oligodendroglial cells are known to de-acetylate the N-acetylaspartate (NAA) synthesized and released by neurons and use it for lipid synthesis. However, the role of NAA regarding their intermediary metabolism remains poorly understood. Two hypotheses were proposed regarding the fate of aspartate after being released by de-acetylation: (1) aspartate is metabolized in the mitochondria of oligodendrocyte lineage cells; (2) aspartate is released to the medium. We report here that aspartoacylase mRNA expression increases when primary rat oligodendrocyte progenitor cells (OPCs) differentiate into mature cells in culture. Moreover, characterising metabolic functions of acetyl coenzyme A and aspartate from NAA catabolism in mature oligodendrocyte cultures after 5 days using isotope-labelled glucose after 5-days of differentiation we found evidence of extensive NAA metabolism. Incubation with [1,6-13C]glucose followed by gas chromatography-mass spectrometry and high performance liquid chromatography analyses of cell extracts and media in the presence and absence of NAA established that the acetate moiety produced by hydrolysis of NAA does not enter mitochondrial metabolism in the form of acetyl coenzyme A. We also resolved the controversy concerning the possible release of aspartate to the medium: aspartate is not released to the medium by oligodendrocytes in amounts detectable by our methods. Therefore we propose that: aspartate released from NAA joins the cytosolic aspartate pool rapidly and takes part in the malate-aspartate shuttle, which transports reducing equivalents from glycolysis into the mitochondria for ATP production and enters the tricarboxylic acid cycle at a slow rate.This work was supported by grants from the UK Multiple Sclerosis Society and from Qatar Foundation. The work was further supported by core funding from the Wellcome Trust and MRC to the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute. The authors acknowledge the excellent technical support in GC-MS and HPLC analysis from Lars Evje (NTNU, Norway).This is the final version of the article. It first appeared from Springer at http://dx.doi.org/10.1007/s11064-016-1985-y

Contrasting prefrontal cortex contributions to episodic memory dysfunction in behavioural variant frontotemporal dementia and alzheimer's disease

Recent evidence has questioned the integrity of episodic memory in behavioural variant frontotemporal dementia (bvFTD), where recall performance is impaired to the same extent as in Alzheimer's disease (AD). While these deficits appear to be mediated by divergent patterns of brain atrophy, there is evidence to suggest that certain prefrontal regions are implicated across both patient groups. In this study we sought to further elucidate the dorsolateral (DLPFC) and ventromedial (VMPFC) prefrontal contributions to episodic memory impairment in bvFTD and AD. Performance on episodic memory tasks and neuropsychological measures typically tapping into either DLPFC or VMPFC functions was assessed in 22 bvFTD, 32 AD patients and 35 age- and education-matched controls. Behaviourally, patient groups did not differ on measures of episodic memory recall or DLPFC-mediated executive functions. BvFTD patients were significantly more impaired on measures of VMPFC-mediated executive functions. Composite measures of the recall, DLPFC and VMPFC task scores were covaried against the T1 MRI scans of all participants to identify regions of atrophy correlating with performance on these tasks. Imaging analysis showed that impaired recall performance is associated with divergent patterns of PFC atrophy in bvFTD and AD. Whereas in bvFTD, PFC atrophy covariates for recall encompassed both DLPFC and VMPFC regions, only the DLPFC was implicated in AD. Our results suggest that episodic memory deficits in bvFTD and AD are underpinned by divergent prefrontal mechanisms. Moreover, we argue that these differences are not adequately captured by existing neuropsychological measures

Zeptomole Electrochemical Detection of Metallothioneins

Thiol-rich peptides and proteins possess a large number of biological activities and may serve as markers for numerous health problems including cancer. Metallothionein (MT), a small molecular mass protein rich in cysteine, may be considered as one of the promising tumour markers. The aim of this paper was to employ chronopotentiometric stripping analysis (CPSA) for highly sensitive detection of MT.In this study, we used adsorptive transfer stripping technique coupled with CPSA for detection of cysteine, glutathione oxidized and reduced, phytochelatin, bovine serum albumin, and metallothionein. Under the optimal conditions, we were able to estimate detection limits down to tens of fg per ml. Further, this method was applied to detect metallothioneins in blood serum obtained from patients with breast cancer and in neuroblastoma cells resistant and sensitive to cisplatin in order to show the possible role of metallothioneins in carcinogenesis. It was found that MT level in blood serum was almost twice higher as compared to the level determined in healthy individuals.This paper brings unique results on the application of ultra-sensitive electroanalytical method for metallothionein detection. The detection limit and other analytical parameters are the best among the parameters of other techniques. In spite of the fact that the paper is mainly focused on metallothionein, it is worth mentioning that successful detection of other biologically important molecules is possible by this method. Coupling of this method with simple isolation methods such as antibody-modified paramagnetic particles may be implemented to lab-on-chip instrument

Calibrative approaches to protein solubility modeling of a mutant series using physicochemical descriptors

A set of physicochemical properties describing a protein of known structure is employed for a calibrative approach to protein solubility. Common hydrodynamic and electrophoretic properties routinely measured in the bio-analytical laboratory such as zeta potential, dipole moment, the second osmotic virial coefficient are first estimated in silico as a function a pH and solution ionic strength starting with the protein crystal structure. The utility of these descriptors in understanding the solubility of a series of ribonuclease Sa mutants is investigated. A simple two parameter model was trained using solubility data of the wild type protein measured at a restricted number of solution pHs. Solubility estimates of the mutants demonstrate that zeta potential and dipole moment may be used to rationalize solubility trends over a wide pH range. Additionally a calibrative model based on the protein’s second osmotic virial coefficient, B22 was developed. A modified DVLO type potential along with a simplified representation of the protein allowed for efficient computation of the second viral coefficient. The standard error of prediction for both models was on the order of 0.3 log S units. These results are very encouraging and demonstrate that these models may be trained with a small number of samples and employed extrapolatively for estimating mutant solubilities

MICE: The muon ionization cooling experiment. Step I: First measurement of emittance with particle physics detectors

Copyright @ 2011 APSThe Muon Ionization Cooling Experiment (MICE) is a strategic R&D project intended to demonstrate the only practical solution to providing high brilliance beams necessary for a neutrino factory or muon collider. MICE is under development at the Rutherford Appleton Laboratory (RAL) in the United Kingdom. It comprises a dedicated beamline to generate a range of input muon emittances and momenta, with time-of-flight and Cherenkov detectors to ensure a pure muon beam. The emittance of the incoming beam will be measured in the upstream magnetic spectrometer with a scintillating fiber tracker. A cooling cell will then follow, alternating energy loss in Liquid Hydrogen (LH2) absorbers to RF cavity acceleration. A second spectrometer, identical to the first, and a second muon identification system will measure the outgoing emittance. In the 2010 run at RAL the muon beamline and most detectors were fully commissioned and a first measurement of the emittance of the muon beam with particle physics (time-of-flight) detectors was performed. The analysis of these data was recently completed and is discussed in this paper. Future steps for MICE, where beam emittance and emittance reduction (cooling) are to be measured with greater accuracy, are also presented.This work was supported by NSF grant PHY-0842798